Rishikesh Prasad
Chandigarh, CH 160012, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction to: ACE2, CALM3 and TNNI3K polymorphisms as potential disease modifiers in hypertrophic and dilated cardiomyopathies.
Journal: Molecular and cellular biochemistry
Published: November 30, 2018
Brain natriuretic peptide in pregnant women with heart disease.
Journal: Obstetric medicine
Published: August 04, 2018
Myocardin ablation in a cardiac-renal rat model.
Journal: Scientific reports
Published: September 18, 2017
ACE2, CALM3 and TNNI3K polymorphisms as potential disease modifiers in hypertrophic and dilated cardiomyopathies.
Journal: Molecular and cellular biochemistry
Published: April 19, 2017
Renin-angiotensin system gene polymorphisms as potential modifiers of hypertrophic and dilated cardiomyopathy phenotypes.
Journal: Molecular and cellular biochemistry
Published: August 03, 2016
MicroRNA-200c modulates DUSP-1 expression in diabetes-induced cardiac hypertrophy.
Journal: Molecular and cellular biochemistry
Published: July 18, 2016
miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy.
Journal: Molecular and cellular biochemistry
Published: February 03, 2016
Role of cardiac TBX20 in dilated cardiomyopathy.
Journal: Molecular and cellular biochemistry
Published: November 09, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026